Endocarditis, Prosthetic valve
Endocarditis, Prosthetic valve is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
PATHOGENS
Some typical distributions of prosthetic valve endocarditis (PVE) pathogens:
- Early < 2 mos following valvular surgery:
- Coagulase-negative staphylococci (25%)
- S. aureus (30%)
- Streptococci (2%)
- Enterococci (8%)
- S. bovis (2%)
- Fungal (9%)
- Gram-negative bacilli (6%)
- Late >2 mos after valvular surgery:
- Coagulase-negative staphylococci (20%)
- S. aureus (18%)
- Streptococci (12%)
- Enterococci (13%)
- S. bovis (7%)
- Fungal (11%)
- Gram-negative bacilli (1%)
- Nosocomial:
- S. aureus (including methicillin-resistant S. aureus)
- Coagulase-negative staphylococci
- Enterococcus
- Candida spp.
-- To view the remaining sections of this topic, please log in or purchase a subscription --
PATHOGENS
Some typical distributions of prosthetic valve endocarditis (PVE) pathogens:
- Early < 2 mos following valvular surgery:
- Coagulase-negative staphylococci (25%)
- S. aureus (30%)
- Streptococci (2%)
- Enterococci (8%)
- S. bovis (2%)
- Fungal (9%)
- Gram-negative bacilli (6%)
- Late >2 mos after valvular surgery:
- Coagulase-negative staphylococci (20%)
- S. aureus (18%)
- Streptococci (12%)
- Enterococci (13%)
- S. bovis (7%)
- Fungal (11%)
- Gram-negative bacilli (1%)
- Nosocomial:
- S. aureus (including methicillin-resistant S. aureus)
- Coagulase-negative staphylococci
- Enterococcus
- Candida spp.
There's more to see -- the rest of this entry is available only to subscribers.
© 2000–2021 Unbound Medicine, Inc. All rights reserved